Anti Malarial Drugs Market is expected to grow at a CAGR of 4.3% during the forecast period and market is expected to reach US$ 1278.2 Mn. by 2029. Anti-malarial drugs are the medicines used to prevent as well as treat malaria. They are also used for avoidance of infection in individuals who travel to malaria-endemic regions. Malaria is a life-threatening disease caused by parasites that are spread toward people through the bites of infected female Anopheles mosquitoes. Malaria is preventable and curable. Anti-malarial medicines are available in the market in the form of tablet, injectables, and capsules.To know about the Research Methodology:- Request Free Sample Report The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. The strong initiatives taken by the various state governments and governing bodies such as U.S. food and drug administration (FDA) to reduce the occurrence of malarial disease throughout the world, also estimated to fuel the demand for the anti-malarial drugs market. Availability of key players, and better R&D facilities & reimbursement policies are the major factors driving the growth of the global anti-malarial drugs market. However, the possible side effects of anti-malarial drugs like insomnia, vivid dreams, mental clouding, dizziness, and anxiety may hinder the growth of the global anti-malarial drugs market. Malaria is considered as a most terrible disease because it causes of death due to lack of availability of the anti-malarial drugs which has become the key opportunity for the growth of the anti-malarial drugs market during the forecast period. There are four major drugs, which currently used to treat malaria include quinoline-related compounds, antifolates, artemisinin derivatives, and antimicrobials. Quinine is a medicine used to treat malaria and babesiosis. Quinine contains the treatment of malaria, owing to Plasmodium falciparum that is resistant to chloroquine when artesunate is not available. Artemisinin is used to reduce the number of Plasmodium parasites in the blood of patients with malaria. Some side effects of artemisinin include skin rash, nausea, vomiting, tremors, and liver issues. Plasmodium falciparum and Plasmodium vivax are the most dangerous types of malaria. Plasmodium falciparum is the most common malaria parasite in South Africa, and it causes the most malaria-related deaths in the world. Plasmodium falciparum multiplies very quickly and causing severe blood loss as well as clogged blood vessels. Plasmodium vivax is mostly found in the Asia Pacific. Plasmodium vivax infects 19-50 million people with malaria every year. Asia-Pacific is the most lucrative region for the anti-malarial drugs, owing to the higher incidence of the malarial diseases in the region and thus is expected to show a robust growth to the global anti-malarial drugs market. The Asia Pacific is account for the highest market share of 30.2% during the forecast period in the anti-malarial drugs market. China & India are the major providers to the growth of Asia Pacific anti-malarial drugs market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global anti-malarial drugs market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in anti-malarial drugs market.
Anti-Malarial Drugs Market Scope: Inquire before buying
Global Anti-Malarial Drugs Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 912.7 Mn. Forecast Period 2022 to 2029 CAGR: 4.3% Market Size in 2029: US $ 1278.2 Mn. Segments Covered: by Drug Type • Quinine • Chloroquine • Amodiaquine • Pyrimethamine • Others by Malaria Type • Plasmodium Falciparum • Plasmodium Vivax • Plasmodium Malariae • Plasmodium Ovale by Mechanism of Action • Resistance • Prevention by Distribution Channel • Hospitals & Retail Pharmacy • E-Commerce • Others Global Anti-Malarial Drugs Market, By Region:
• North America • Europe • Middle East & Africa • Asia Pacific • South AmericaThe Key Players Operating In the Global Anti-Malarial Drugs Market:
• Mylan Labs • Cipla • GlaxoSmithKline • Novartis • Roche • Bayer AG • Lincoln Pharmaceuticals • Strides Pharma Science • Glenmark Pharmaceuticals • Alliance Pharmaceuticals • F. Hoffmann-La Roche AG • Alvizia Healthcare Pvt. Ltd. • Ipca Laboratories Ltd. • Merck & Co., Inc • Sun Pharmaceutical Industries Ltd. • Zydus Cadila. • Ranbaxy Laboratories Frequently Asked Questions: 1. Which region has the largest share in Global Anti-Malarial Drugs Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Anti-Malarial Drugs Market? Ans: The Global Anti-Malarial Drugs Market is growing at a CAGR of 4.3% during forecasting period 2022-2029. 3. What is scope of the Global Anti-Malarial Drugs market report? Ans: Global Anti-Malarial Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Anti-Malarial Drugs market? Ans: The important key players in the Global Anti-Malarial Drugs Market are – Mylan Labs, Cipla, GlaxoSmithKline, Novartis, Roche, Bayer AG, Lincoln Pharmaceuticals, Strides Pharma Science, Glenmark Pharmaceuticals, Alliance Pharmaceuticals, F. Hoffmann-La Roche AG, Alvizia Healthcare Pvt. Ltd., Ipca Laboratories Ltd., Merck & Co., Inc, Sun Pharmaceutical Industries Ltd., Zydus Cadila., and Ranbaxy Laboratories. 5. What is the study period of this market? Ans: The Global Anti-Malarial Drugs Market is studied from 2021 to 2029.
Global anti-malarial drugs market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Anti-Malarial Drugs Market Size, by Market Value (US$ Mn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies in Global Anti-Malarial Drugs Market 5. Supply Side and Demand Side Indicators 6. Global Anti-Malarial Drugs Market Analysis and Forecast 6.1. Global Anti-Malarial Drugs Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Anti-Malarial Drugs Market Analysis and Forecast, by Drug Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 7.4. Global Anti-Malarial Drugs Market Size (US$ Mn) Forecast, by Drug Type 7.5. Global Anti-Malarial Drugs Market Analysis, by Drug Type 7.6. Global Anti-Malarial Drugs Market Attractiveness Analysis, by Drug Type 8. Global Anti-Malarial Drugs Market Analysis and Forecast, by Malaria Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 8.4. Global Anti-Malarial Drugs Market Size (US$ Mn) Forecast, by Malaria Type 8.5. Global Anti-Malarial Drugs Market Analysis, by Malaria Type 8.6. Global Anti-Malarial Drugs Market Attractiveness Analysis, by Malaria Type 9. Global Anti-Malarial Drugs Market Analysis and Forecast, by Mechanism of Action 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 9.4. Global Anti-Malarial Drugs Market Size (US$ Mn) Forecast, by Mechanism of Action 9.5. Global Anti-Malarial Drugs Market Analysis, by Mechanism of Action 9.6. Global Anti-Malarial Drugs Market Attractiveness Analysis, by Mechanism of Action 10. Global Anti-Malarial Drugs Market Analysis and Forecast, by Distribution Channel type 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 10.4. Global Anti-Malarial Drugs Market Size (US$ Mn) Forecast, by Distribution Channel type 10.5. Global Anti-Malarial Drugs Market Analysis, by Distribution Channel type 10.6. Global Anti-Malarial Drugs Market Attractiveness Analysis, by Distribution Channel type 11. Global Anti-Malarial Drugs Market Analysis, by Region 11.1. Global Anti-Malarial Drugs Market Value Share Analysis, by Region 11.2. Global Anti-Malarial Drugs Market Size (US$ Mn) Forecast, by Region 11.3. Global Anti-Malarial Drugs Market Attractiveness Analysis, by Region 12. North America Anti-Malarial Drugs Market Analysis 12.1. Key Findings 12.2. North America Anti-Malarial Drugs Market Overview 12.3. North America Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 12.4. North America Anti-Malarial Drugs Market Forecast, by Drug Type 12.4.1. Quinine 12.4.2. Chloroquine 12.4.3. Amodiaquine 12.4.4. Pyrimethamine 12.4.5. Others 12.5. North America Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 12.6. North America Anti-Malarial Drugs Market Forecast, by Malaria Type 12.6.1. Plasmodium Falciparum 12.6.2. Plasmodium Vivax 12.6.3. Plasmodium Malariae 12.6.4. Plasmodium Ovale 12.7. North America Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 12.8. North America Anti-Malarial Drugs Market Forecast, by Mechanism of Action 12.8.1. Resistance 12.8.2. Prevention 12.9. North America Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 12.10. North America Anti-Malarial Drugs Market Forecast, by Distribution Channel type 12.10.1. Hospitals & Retail Pharmacy 12.10.2. E-Commerce 12.10.3. Others 12.11. North America Anti-Malarial Drugs Market Value Share Analysis, by Country 12.12. North America Anti-Malarial Drugs Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Anti-Malarial Drugs Market Analysis, by Country 12.14. U.S. Anti-Malarial Drugs Market Forecast, by Drug Type 12.14.1. Quinine 12.14.2. Chloroquine 12.14.3. Amodiaquine 12.14.4. Pyrimethamine 12.14.5. Others 12.15. U.S. Anti-Malarial Drugs Market Forecast, by Malaria Type 12.15.1. Plasmodium Falciparum 12.15.2. Plasmodium Vivax 12.15.3. Plasmodium Malariae 12.15.4. Plasmodium Ovale 12.16. U.S. Anti-Malarial Drugs Market Forecast, by Mechanism of Action 12.16.1. Resistance 12.16.2. Prevention 12.17. U.S. Anti-Malarial Drugs Market Forecast, by Distribution Channel type 12.17.1. Hospitals & Retail Pharmacy 12.17.2. E-Commerce 12.17.3. Others 12.18. Canada Anti-Malarial Drugs Market Forecast, by Drug Type 12.18.1. Quinine 12.18.2. Chloroquine 12.18.3. Amodiaquine 12.18.4. Pyrimethamine 12.18.5. Others 12.19. Canada Anti-Malarial Drugs Market Forecast, by Malaria Type 12.19.1. Plasmodium Falciparum 12.19.2. Plasmodium Vivax 12.19.3. Plasmodium Malariae 12.19.4. Plasmodium Ovale 12.20. Canada Anti-Malarial Drugs Market Forecast, by Mechanism of Action 12.20.1. Resistance 12.20.2. Prevention 12.21. Canada Anti-Malarial Drugs Market Forecast, by Distribution Channel type 12.21.1. Hospitals & Retail Pharmacy 12.21.2. E-Commerce 12.21.3. Others 12.22. North America Anti-Malarial Drugs Market Attractiveness Analysis 12.22.1. By Drug Type 12.22.2. By Malaria Type 12.22.3. By Mechanism of Action 12.22.4. By Distribution Channel type 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Anti-Malarial Drugs Market Analysis 13.1. Key Findings 13.2. Europe Anti-Malarial Drugs Market Overview 13.3. Europe Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 13.4. Europe Anti-Malarial Drugs Market Forecast, by Drug Type 13.4.1. Quinine 13.4.2. Chloroquine 13.4.3. Amodiaquine 13.4.4. Pyrimethamine 13.4.5. Others 13.5. Europe Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 13.6. Europe Anti-Malarial Drugs Market Forecast, by Malaria Type 13.6.1. Plasmodium Falciparum 13.6.2. Plasmodium Vivax 13.6.3. Plasmodium Malariae 13.6.4. Plasmodium Ovale 13.7. Europe Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 13.8. Europe Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.8.1. Resistance 13.8.2. Prevention 13.9. Europe Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 13.10. Europe Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.10.1. Hospitals & Retail Pharmacy 13.10.2. E-Commerce 13.10.3. Others 13.11. Europe Anti-Malarial Drugs Market Value Share Analysis, by Country 13.12. Europe Anti-Malarial Drugs Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Anti-Malarial Drugs Market Analysis, by Country 13.14. Germany Anti-Malarial Drugs Market Forecast, by Drug Type 13.14.1. Quinine 13.14.2. Chloroquine 13.14.3. Amodiaquine 13.14.4. Pyrimethamine 13.14.5. Others 13.15. Germany Anti-Malarial Drugs Market Forecast, by Malaria Type 13.15.1. Plasmodium Falciparum 13.15.2. Plasmodium Vivax 13.15.3. Plasmodium Malariae 13.15.4. Plasmodium Ovale 13.16. Germany Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.16.1. Resistance 13.16.2. Prevention 13.17. Germany Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.17.1. Hospitals & Retail Pharmacy 13.17.2. E-Commerce 13.17.3. Others 13.18. U.K. Anti-Malarial Drugs Market Forecast, by Drug Type 13.18.1. Quinine 13.18.2. Chloroquine 13.18.3. Amodiaquine 13.18.4. Pyrimethamine 13.18.5. Others 13.19. U.K. Anti-Malarial Drugs Market Forecast, by Malaria Type 13.19.1. Plasmodium Falciparum 13.19.2. Plasmodium Vivax 13.19.3. Plasmodium Malariae 13.19.4. Plasmodium Ovale 13.20. U.K. Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.20.1. Resistance 13.20.2. Prevention 13.21. U.K. Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.21.1. Hospitals & Retail Pharmacy 13.21.2. E-Commerce 13.21.3. Others 13.22. France Anti-Malarial Drugs Market Forecast, by Drug Type 13.22.1. Quinine 13.22.2. Chloroquine 13.22.3. Amodiaquine 13.22.4. Pyrimethamine 13.22.5. Others 13.23. France Anti-Malarial Drugs Market Forecast, by Malaria Type 13.23.1. Plasmodium Falciparum 13.23.2. Plasmodium Vivax 13.23.3. Plasmodium Malariae 13.23.4. Plasmodium Ovale 13.24. France Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.24.1. Resistance 13.24.2. Prevention 13.25. France Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.25.1. Hospitals & Retail Pharmacy 13.25.2. E-Commerce 13.25.3. Others 13.26. Italy Anti-Malarial Drugs Market Forecast, by Drug Type 13.26.1. Quinine 13.26.2. Chloroquine 13.26.3. Amodiaquine 13.26.4. Pyrimethamine 13.26.5. Others 13.27. Italy Anti-Malarial Drugs Market Forecast, by Malaria Type 13.27.1. Plasmodium Falciparum 13.27.2. Plasmodium Vivax 13.27.3. Plasmodium Malariae 13.27.4. Plasmodium Ovale 13.28. Italy Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.28.1. Resistance 13.28.2. Prevention 13.29. Italy Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.29.1. Hospitals & Retail Pharmacy 13.29.2. E-Commerce 13.29.3. Others 13.30. Spain Anti-Malarial Drugs Market Forecast, by Drug Type 13.30.1. Quinine 13.30.2. Chloroquine 13.30.3. Amodiaquine 13.30.4. Pyrimethamine 13.30.5. Others 13.31. Spain Anti-Malarial Drugs Market Forecast, by Malaria Type 13.31.1. Plasmodium Falciparum 13.31.2. Plasmodium Vivax 13.31.3. Plasmodium Malariae 13.31.4. Plasmodium Ovale 13.32. Spain Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.32.1. Resistance 13.32.2. Prevention 13.33. Spain Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.33.1. Hospitals & Retail Pharmacy 13.33.2. E-Commerce 13.33.3. Others 13.34. Rest of Europe Anti-Malarial Drugs Market Forecast, by Drug Type 13.34.1. Quinine 13.34.2. Chloroquine 13.34.3. Amodiaquine 13.34.4. Pyrimethamine 13.34.5. Others 13.35. Rest of Europe Anti-Malarial Drugs Market Forecast, by Malaria Type 13.35.1. Plasmodium Falciparum 13.35.2. Plasmodium Vivax 13.35.3. Plasmodium Malariae 13.35.4. Plasmodium Ovale 13.36. Rest of Europe Anti-Malarial Drugs Market Forecast, by Mechanism of Action 13.36.1. Resistance 13.36.2. Prevention 13.37. Rest Of Europe Anti-Malarial Drugs Market Forecast, by Distribution Channel type 13.37.1. Hospitals & Retail Pharmacy 13.37.2. E-Commerce 13.37.3. Others 13.38. Europe Anti-Malarial Drugs Market Attractiveness Analysis 13.38.1. By Drug Type 13.38.2. By Malaria Type 13.38.3. By Mechanism of Action 13.38.4. By Distribution Channel type 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Anti-Malarial Drugs Market Analysis 14.1. Key Findings 14.2. Asia Pacific Anti-Malarial Drugs Market Overview 14.3. Asia Pacific Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 14.4. Asia Pacific Anti-Malarial Drugs Market Forecast, by Drug Type 14.4.1. Quinine 14.4.2. Chloroquine 14.4.3. Amodiaquine 14.4.4. Pyrimethamine 14.4.5. Others 14.5. Asia Pacific Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 14.6. Asia Pacific Anti-Malarial Drugs Market Forecast, by Malaria Type 14.6.1. Plasmodium Falciparum 14.6.2. Plasmodium Vivax 14.6.3. Plasmodium Malariae 14.6.4. Plasmodium Ovale 14.7. Asia Pacific Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 14.8. Asia Pacific Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.8.1. Resistance 14.8.2. Prevention 14.9. Asia Pacific Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 14.10. Asia Pacific Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.10.1. Hospitals & Retail Pharmacy 14.10.2. E-Commerce 14.10.3. Others 14.11. Asia Pacific Anti-Malarial Drugs Market Value Share Analysis, by Country 14.12. Asia Pacific Anti-Malarial Drugs Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Anti-Malarial Drugs Market Analysis, by Country 14.14. China Anti-Malarial Drugs Market Forecast, by Drug Type 14.14.1. Quinine 14.14.2. Chloroquine 14.14.3. Amodiaquine 14.14.4. Pyrimethamine 14.14.5. Others 14.15. China Anti-Malarial Drugs Market Forecast, by Malaria Type 14.15.1. Plasmodium Falciparum 14.15.2. Plasmodium Vivax 14.15.3. Plasmodium Malariae 14.15.4. Plasmodium Ovale 14.16. China Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.16.1. Resistance 14.16.2. Prevention 14.17. China Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.17.1. Hospitals & Retail Pharmacy 14.17.2. E-Commerce 14.17.3. Others 14.18. India Anti-Malarial Drugs Market Forecast, by Drug Type 14.18.1. Quinine 14.18.2. Chloroquine 14.18.3. Amodiaquine 14.18.4. Pyrimethamine 14.18.5. Others 14.19. India Anti-Malarial Drugs Market Forecast, by Malaria Type 14.19.1. Plasmodium Falciparum 14.19.2. Plasmodium Vivax 14.19.3. Plasmodium Malariae 14.19.4. Plasmodium Ovale 14.20. India Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.20.1. Resistance 14.20.2. Prevention 14.21. India Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.21.1. Hospitals & Retail Pharmacy 14.21.2. E-Commerce 14.21.3. Others 14.22. Japan Anti-Malarial Drugs Market Forecast, by Drug Type 14.22.1. Quinine 14.22.2. Chloroquine 14.22.3. Amodiaquine 14.22.4. Pyrimethamine 14.22.5. Others 14.23. Japan Anti-Malarial Drugs Market Forecast, by Malaria Type 14.23.1. Plasmodium Falciparum 14.23.2. Plasmodium Vivax 14.23.3. Plasmodium Malariae 14.23.4. Plasmodium Ovale 14.24. Japan Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.24.1. Resistance 14.24.2. Prevention 14.25. Japan Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.25.1. Hospitals & Retail Pharmacy 14.25.2. E-Commerce 14.25.3. Others 14.26. ASEAN Anti-Malarial Drugs Market Forecast, by Drug Type 14.26.1. Quinine 14.26.2. Chloroquine 14.26.3. Amodiaquine 14.26.4. Pyrimethamine 14.26.5. Others 14.27. ASEAN Anti-Malarial Drugs Market Forecast, by Malaria Type 14.27.1. Plasmodium Falciparum 14.27.2. Plasmodium Vivax 14.27.3. Plasmodium Malariae 14.27.4. Plasmodium Ovale 14.28. ASEAN Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.28.1. Resistance 14.28.2. Prevention 14.29. ASEAN Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.29.1. Hospitals & Retail Pharmacy 14.29.2. E-Commerce 14.29.3. Others 14.30. Rest of Asia Pacific Anti-Malarial Drugs Market Forecast, by Drug Type 14.30.1. Quinine 14.30.2. Chloroquine 14.30.3. Amodiaquine 14.30.4. Pyrimethamine 14.30.5. Others 14.31. Rest of Asia Pacific Anti-Malarial Drugs Market Forecast, by Malaria Type 14.31.1. Plasmodium Falciparum 14.31.2. Plasmodium Vivax 14.31.3. Plasmodium Malariae 14.31.4. Plasmodium Ovale 14.32. Rest of Asia Pacific Anti-Malarial Drugs Market Forecast, by Mechanism of Action 14.32.1. Resistance 14.32.2. Prevention 14.33. Rest of Asia Pacific Anti-Malarial Drugs Market Forecast, by Distribution Channel type 14.33.1. Hospitals & Retail Pharmacy 14.33.2. E-Commerce 14.33.3. Others 14.34. Asia Pacific Anti-Malarial Drugs Market Attractiveness Analysis 14.34.1. By Drug Type 14.34.2. By Malaria Type 14.34.3. By Mechanism of Action 14.34.4. By Distribution Channel type 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Anti-Malarial Drugs Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Anti-Malarial Drugs Market Overview 15.3. Middle East & Africa Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 15.4. Middle East & Africa Anti-Malarial Drugs Market Forecast, by Drug Type 15.4.1. Quinine 15.4.2. Chloroquine 15.4.3. Amodiaquine 15.4.4. Pyrimethamine 15.4.5. Others 15.5. Middle East & Africa Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 15.6. Middle East & Africa Anti-Malarial Drugs Market Forecast, by Malaria Type 15.6.1. Plasmodium Falciparum 15.6.2. Plasmodium Vivax 15.6.3. Plasmodium Malariae 15.6.4. Plasmodium Ovale 15.7. Middle East & Africa Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 15.8. Middle East & Africa Anti-Malarial Drugs Market Forecast, by Mechanism of Action 15.8.1. Resistance 15.8.2. Prevention 15.9. Middle East & Africa Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 15.10. Middle East & Africa Anti-Malarial Drugs Market Forecast, by Distribution Channel type 15.10.1. Hospitals & Retail Pharmacy 15.10.2. E-Commerce 15.10.3. Others 15.11. Middle East & Africa Anti-Malarial Drugs Market Value Share Analysis, by Country 15.12. Middle East & Africa Anti-Malarial Drugs Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Anti-Malarial Drugs Market Analysis, by Country 15.14. GCC Anti-Malarial Drugs Market Forecast, by Drug Type 15.14.1. Quinine 15.14.2. Chloroquine 15.14.3. Amodiaquine 15.14.4. Pyrimethamine 15.14.5. Others 15.15. GCC Anti-Malarial Drugs Market Forecast, by Malaria Type 15.15.1. Plasmodium Falciparum 15.15.2. Plasmodium Vivax 15.15.3. Plasmodium Malariae 15.15.4. Plasmodium Ovale 15.16. GCC Anti-Malarial Drugs Market Forecast, by Mechanism of Action 15.16.1. Resistance 15.16.2. Prevention 15.17. GCC Anti-Malarial Drugs Market Forecast, by Distribution Channel type 15.17.1. Hospitals & Retail Pharmacy 15.17.2. E-Commerce 15.17.3. Others 15.18. South Africa Anti-Malarial Drugs Market Forecast, by Drug Type 15.18.1. Quinine 15.18.2. Chloroquine 15.18.3. Amodiaquine 15.18.4. Pyrimethamine 15.18.5. Others 15.19. South Africa Anti-Malarial Drugs Market Forecast, by Malaria Type 15.19.1. Plasmodium Falciparum 15.19.2. Plasmodium Vivax 15.19.3. Plasmodium Malariae 15.19.4. Plasmodium Ovale 15.20. South Africa Anti-Malarial Drugs Market Forecast, by Mechanism of Action 15.20.1. Resistance 15.20.2. Prevention 15.21. South Africa Anti-Malarial Drugs Market Forecast, by Distribution Channel type 15.21.1. Hospitals & Retail Pharmacy 15.21.2. E-Commerce 15.21.3. Others 15.22. Rest of Middle East & Africa Anti-Malarial Drugs Market Forecast, by Drug Type 15.22.1. Quinine 15.22.2. Chloroquine 15.22.3. Amodiaquine 15.22.4. Pyrimethamine 15.22.5. Others 15.23. Rest of Middle East & Africa Anti-Malarial Drugs Market Forecast, by Malaria Type 15.23.1. Plasmodium Falciparum 15.23.2. Plasmodium Vivax 15.23.3. Plasmodium Malariae 15.23.4. Plasmodium Ovale 15.24. Rest of Middle East & Africa Anti-Malarial Drugs Market Forecast, by Mechanism of Action 15.24.1. Resistance 15.24.2. Prevention 15.25. Rest of Middle East & Africa Anti-Malarial Drugs Market Forecast, by Distribution Channel type 15.25.1. Hospitals & Retail Pharmacy 15.25.2. E-Commerce 15.25.3. Others 15.26. Middle East & Africa Anti-Malarial Drugs Market Attractiveness Analysis 15.26.1. By Drug Type 15.26.2. By Malaria Type 15.26.3. By Mechanism of Action 15.26.4. By Distribution Channel type 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Anti-Malarial Drugs Market Analysis 16.1. Key Findings 16.2. South America Anti-Malarial Drugs Market Overview 16.3. South America Anti-Malarial Drugs Market Value Share Analysis, by Drug Type 16.4. South America Anti-Malarial Drugs Market Forecast, by Drug Type 16.4.1. Quinine 16.4.2. Chloroquine 16.4.3. Amodiaquine 16.4.4. Pyrimethamine 16.4.5. Others 16.5. South America Anti-Malarial Drugs Market Value Share Analysis, by Malaria Type 16.6. South America Anti-Malarial Drugs Market Forecast, by Malaria Type 16.6.1. Plasmodium Falciparum 16.6.2. Plasmodium Vivax 16.6.3. Plasmodium Malariae 16.6.4. Plasmodium Ovale 16.7. South America Anti-Malarial Drugs Market Value Share Analysis, by Mechanism of Action 16.8. South America Anti-Malarial Drugs Market Forecast, by Mechanism of Action 16.8.1. Resistance 16.8.2. Prevention 16.9. South America Anti-Malarial Drugs Market Value Share Analysis, by Distribution Channel type 16.10. South America Anti-Malarial Drugs Market Forecast, by Distribution Channel type 16.10.1. Hospitals & Retail Pharmacy 16.10.2. E-Commerce 16.10.3. Others 16.11. South America Anti-Malarial Drugs Market Value Share Analysis, by Country 16.12. South America Anti-Malarial Drugs Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Anti-Malarial Drugs Market Analysis, by Country 16.14. Brazil Anti-Malarial Drugs Market Forecast, by Drug Type 16.14.1. Quinine 16.14.2. Chloroquine 16.14.3. Amodiaquine 16.14.4. Pyrimethamine 16.14.5. Others 16.15. Brazil Anti-Malarial Drugs Market Forecast, by Malaria Type 16.15.1. Plasmodium Falciparum 16.15.2. Plasmodium Vivax 16.15.3. Plasmodium Malariae 16.15.4. Plasmodium Ovale 16.16. Brazil Anti-Malarial Drugs Market Forecast, by Mechanism of Action 16.16.1. Resistance 16.16.2. Prevention 16.17. Brazil Anti-Malarial Drugs Market Forecast, by Distribution Channel type 16.17.1. Hospitals & Retail Pharmacy 16.17.2. E-Commerce 16.17.3. Others 16.18. Mexico Anti-Malarial Drugs Market Forecast, by Drug Type 16.18.1. Quinine 16.18.2. Chloroquine 16.18.3. Amodiaquine 16.18.4. Pyrimethamine 16.18.5. Others 16.19. Mexico Anti-Malarial Drugs Market Forecast, by Malaria Type 16.19.1. Plasmodium Falciparum 16.19.2. Plasmodium Vivax 16.19.3. Plasmodium Malariae 16.19.4. Plasmodium Ovale 16.20. Mexico Anti-Malarial Drugs Market Forecast, by Mechanism of Action 16.20.1. Resistance 16.20.2. Prevention 16.21. Mexico Anti-Malarial Drugs Market Forecast, by Distribution Channel type 16.21.1. Hospitals & Retail Pharmacy 16.21.2. E-Commerce 16.21.3. Others 16.22. Rest of South America Anti-Malarial Drugs Market Forecast, by Drug Type 16.22.1. Quinine 16.22.2. Chloroquine 16.22.3. Amodiaquine 16.22.4. Pyrimethamine 16.22.5. Others 16.23. Rest of South America Anti-Malarial Drugs Market Forecast, by Malaria Type 16.23.1. Plasmodium Falciparum 16.23.2. Plasmodium Vivax 16.23.3. Plasmodium Malariae 16.23.4. Plasmodium Ovale 16.24. Rest of South America Anti-Malarial Drugs Market Forecast, by Mechanism of Action 16.24.1. Resistance 16.24.2. Prevention 16.25. Rest of South America Anti-Malarial Drugs Market Forecast, by Distribution Channel type 16.25.1. Hospitals & Retail Pharmacy 16.25.2. E-Commerce 16.25.3. Others 16.26. South America Anti-Malarial Drugs Market Attractiveness Analysis 16.26.1. By Drug Type 16.26.2. By Malaria Type 16.26.3. By Mechanism of Action 16.26.4. By Distribution Channel type 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Alliance Pharmaceuticals 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Drug Type Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Manufacturing Footprint 17.3.2. Mylan Labs 17.3.3. Cipla 17.3.4. GlaxoSmithKline 17.3.5. Novartis 17.3.6. Roche 17.3.7. Bayer AG 17.3.8. Lincoln Pharmaceuticals 17.3.9. Strides Pharma Science 17.3.10. Glenmark Pharmaceuticals 17.3.11. F. Hoffmann-La Roche AG 17.3.12. Alvizia Healthcare Pvt. Ltd. 17.3.13. Ipca Laboratories Ltd. 17.3.14. Merck & Co., Inc 17.3.15. Sun Pharmaceutical Industries Ltd. 17.3.16. Zydus Cadila. 17.3.17. Ranbaxy Laboratories 18. Primary Key Insights